Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells ; volume:11 ; number:1 ; day:12 ; month:8 ; year:2013 ; pages:1-11 ; date:12.2013
Journal of translational medicine ; 11, Heft 1 (12.8.2013), 1-11, 12.2013
- Urheber
-
Schuberth, Petra C.
- Beteiligte Personen und Organisationen
-
Hagedorn, Christian
Jensen, Shawn M.
Gulati, Pratiksha
van den Broek, Maries
Mischo, Axel
Soltermann, Alex
Jüngel, Astrid
Marroquin Belaunzaran, Osiris
Stahel, Rolf
Renner, Christoph
Petrausch, Ulf
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-11-187
- URN
-
urn:nbn:de:1111-2016041444617
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schuberth, Petra C.
- Hagedorn, Christian
- Jensen, Shawn M.
- Gulati, Pratiksha
- van den Broek, Maries
- Mischo, Axel
- Soltermann, Alex
- Jüngel, Astrid
- Marroquin Belaunzaran, Osiris
- Stahel, Rolf
- Renner, Christoph
- Petrausch, Ulf
- SpringerLink (Online service)
Ähnliche Objekte (12)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
Molecular biological analysis of malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
GAS5 long non-coding RNA in malignant pleural mesothelioma